This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2024 Zacks Investment Research | 10 S Riverside Plaza Suite #1600 | Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +24.10% per year. These returns cover a period from January 1, 1988 through October 7, 2024. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
Countdown to Nutrien (NTR) Q3 Earnings: A Look at Estimates Beyond Revenue and EPS
by Zacks Equity Research
Evaluate the expected performance of Nutrien (NTR) for the quarter ended September 2024, looking beyond the conventional Wall Street top-and-bottom-line estimates and examining some of its key metrics for better insight.
Nutrien (NTR) Earnings Expected to Grow: Should You Buy?
by Zacks Equity Research
Nutrien (NTR) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
CF Industries Stock Soars 26% in 3 Months: Time to Buy Now?
by Anindya Barman
CF presents an attractive investment case backed by favorable nitrogen demand fundamentals, rising earnings estimates and a healthy dividend yield.
Reasons Why You Should Hold Nutrien Stock in Your Portfolio Now
by Zacks Equity Research
While NTR faces pricing pressure, it gains on healthy demand for fertilizers, backed by the strength in global agriculture markets.
AdvanSix Stock Dirt Cheap: Should You Buy Now?
by Anindya Barman
With favorable demand and pricing fundamentals, solid financial health and rising earnings estimates, ASIX presents a compelling investment case.
Why Is Nutrien (NTR) Up 1% Since Last Earnings Report?
by Zacks Equity Research
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Do Options Traders Know Something About Nurtrien (NTR) Stock We Don't?
by Zacks Equity Research
Investors need to pay close attention to Nutrien (NTR) stock based on the movements in the options market lately.
CF Industries' Shares Up 9% in a Month: Should You Buy the Stock?
by Anindya Barman
While CF benefits from higher nitrogen demand in key regions backed by supportive agricultural fundamentals, weaker prices cast a pall on its prospects.
Here's Why You Should Retain Nutrien Stock in Your Portfolio
by Zacks Equity Research
While NTR is exposed to pricing pressure, it benefits from healthy demand for fertilizers, backed by the strength in global agriculture markets.
Nutrien (NTR) Q2 Earnings Beat Estimates, Revenues Miss
by Zacks Equity Research
Nutrien's (NTR) earnings beat estimates while sales miss the same on lower selling prices in the second quarter.
Nutrien (NTR) Q2 Earnings: Taking a Look at Key Metrics Versus Estimates
by Zacks Equity Research
Although the revenue and EPS for Nutrien (NTR) give a sense of how its business performed in the quarter ended June 2024, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Nutrien (NTR) Beats Q2 Earnings Estimates
by Zacks Equity Research
Nutrien (NTR) delivered earnings and revenue surprises of 9.86% and 6.77%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
Mosaic (MOS) Lags Q2 Earnings and Revenue Estimates
by Zacks Equity Research
Mosaic (MOS) delivered earnings and revenue surprises of -20.59% and 3.90%, respectively, for the quarter ended June 2024. Do the numbers hold clues to what lies ahead for the stock?
CF Industries (CF) to Report Q2 Earnings: What's in the Offing?
by Zacks Equity Research
CF Industries' (CF) second-quarter results are likely to reflect the impacts of softer nitrogen prices.
Ahead of Nutrien (NTR) Q2 Earnings: Get Ready With Wall Street Estimates for Key Metrics
by Zacks Equity Research
Get a deeper insight into the potential performance of Nutrien (NTR) for the quarter ended June 2024 by going beyond Wall Street's top -and-bottom-line estimates and examining the estimates for some of its key metrics.
Nutrien (NTR) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
by Zacks Equity Research
Nutrien (NTR) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
How to Boost Your Portfolio with Top Basic Materials Stocks Set to Beat Earnings
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
How to Find Strong Basic Materials Stocks Slated for Positive Earnings Surprises
by Zacks Equity Research
Why investors should use the Zacks Earnings ESP tool to help find stocks that are poised to top quarterly earnings estimates.
These 2 Basic Materials Stocks Could Beat Earnings: Why They Should Be on Your Radar
by Zacks Equity Research
The Zacks Earnings ESP is a great way to find potential earnings surprises. Why investors should take advantage now.
Nutrien (NTR) Prices $1 Billion of 3-Year & 10-Year Senior Notes
by Zacks Equity Research
The senior notes will be unsecured and will rank on an equal footing with Nutrien's (NTR) current senior unsecured debt.
Zacks Industry Outlook Nutrien, ICL and Intrepid Potash
by Zacks Equity Research
Nutrien, ICL and Intrepid Potash have been highlighted in this Industry Outlook article.
3 Top Fertilizer Stocks to Watch From a Promising Industry
by Anindya Barman
Favorable demand in major markets for crop nutrients, backed by the strength in global agriculture markets, should enable the Zacks Fertilizers industry to thrive. NTR, ICL and IPI should benefit from supportive industry fundamentals.
Nutrien (NTR) Down 4% Since Last Earnings Report: Can It Rebound?
by Zacks Equity Research
Nutrien (NTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Samsara's (IOT) Q1 Earnings Beat Estimates, Revenues Up Y/Y
by Zacks Equity Research
Samsara's (IOT) fiscal first-quarter performance benefits from expanding its customer base.
Here's Why You Should Retain Nutrien (NTR) in Your Portfolio
by Zacks Equity Research
While Nutrien (NTR) is exposed to pricing pressure, it benefits from solid demand for fertilizers, backed by the strength in global agriculture markets.